{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T23:08:17Z","timestamp":1781910497076,"version":"3.54.5"},"reference-count":45,"publisher":"International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BST"],"published-print":{"date-parts":[[2017]]},"DOI":"10.5582\/bst.2017.01056","type":"journal-article","created":{"date-parts":[[2017,5,5]],"date-time":"2017-05-05T22:06:42Z","timestamp":1494022002000},"page":"267-273","source":"Crossref","is-referenced-by-count":28,"title":["Traditional Chinese medicine for human papillomavirus (HPV) infections: A systematic review"],"prefix":"10.5582","volume":"11","author":[{"given":"Jing","family":"Lin","sequence":"first","affiliation":[{"name":"Laboratory for Reproductive Immunology, Hospital & Institute of Obstetrics and Gynecology, IBS, Shanghai Medical College, Fudan University"},{"name":"Shanghai Key Laboratory of Female Reproductive Endocrine-related Diseases"},{"name":"The Academy of Integrative Medicine of Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanting","family":"Chen","sequence":"additional","affiliation":[{"name":"Laboratory for Reproductive Immunology, Hospital & Institute of Obstetrics and Gynecology, IBS, Shanghai Medical College, Fudan University"},{"name":"Shanghai Key Laboratory of Female Reproductive Endocrine-related Diseases"},{"name":"The Academy of Integrative Medicine of Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemin","family":"Qiu","sequence":"additional","affiliation":[{"name":"Laboratory for Reproductive Immunology, Hospital & Institute of Obstetrics and Gynecology, IBS, Shanghai Medical College, Fudan University"},{"name":"Shanghai Key Laboratory of Female Reproductive Endocrine-related Diseases"},{"name":"The Academy of Integrative Medicine of Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Zhang","sequence":"additional","affiliation":[{"name":"Laboratory for Reproductive Immunology, Hospital & Institute of Obstetrics and Gynecology, IBS, Shanghai Medical College, Fudan University"},{"name":"Shanghai Key Laboratory of Female Reproductive Endocrine-related Diseases"},{"name":"The Academy of Integrative Medicine of Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiting","family":"Guo","sequence":"additional","affiliation":[{"name":"Public Health of Zhejiang University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Wang","sequence":"additional","affiliation":[{"name":"Laboratory for Reproductive Immunology, Hospital & Institute of Obstetrics and Gynecology, IBS, Shanghai Medical College, Fudan University"},{"name":"Shanghai Key Laboratory of Female Reproductive Endocrine-related Diseases"},{"name":"The Academy of Integrative Medicine of Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyan","family":"Wang","sequence":"additional","affiliation":[{"name":"Laboratory for Reproductive Immunology, Hospital & Institute of Obstetrics and Gynecology, IBS, Shanghai Medical College, Fudan University"},{"name":"Shanghai Key Laboratory of Female Reproductive Endocrine-related Diseases"},{"name":"The Academy of Integrative Medicine of Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-J\u00fcrgen","family":"Gober","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Kepler University Clinic, Neuromed Campus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajin","family":"Li","sequence":"additional","affiliation":[{"name":"Laboratory for Reproductive Immunology, Hospital & Institute of Obstetrics and Gynecology, IBS, Shanghai Medical College, Fudan University"},{"name":"Shanghai Key Laboratory of Female Reproductive Endocrine-related Diseases"},{"name":"The Academy of Integrative Medicine of Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[{"name":"Laboratory for Reproductive Immunology, Hospital & Institute of Obstetrics and Gynecology, IBS, Shanghai Medical College, Fudan University"},{"name":"Shanghai Key Laboratory of Female Reproductive Endocrine-related Diseases"},{"name":"The Academy of Integrative Medicine of Fudan University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3542","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Park IU, Introcaso C, Dunne EF. Human papillomavirus and genital warts: A review of the evidence for the 2015 centers for disease control and prevention sexually transmitted diseases treatment guidelines. Clin Infect Dis. 2015; 61:S849-855.","DOI":"10.1093\/cid\/civ813"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Zeng Z, Austin RM, He X, Chen X, Guo X, Zheng B, Wu S, Yang H, Zhao C. Prevalence of high-risk human papillomavirus infection in China: Analysis of 671,163 human papillomavirus test results from China&apos;s largest college of American pathologists-certified laboratory. Am J Clin Pathol. 2016; 145:622-625.","DOI":"10.1093\/ajcp\/aqw010"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Forman D, Martel CD, Lacey CJ, Soerjomataram I, Tieulent JL, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, Franceschi S. Global burden of human papillomavirus and related diseases. Vaccine. 2012; 30:12-23.","DOI":"10.1016\/j.vaccine.2012.07.055"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Denny L. Epidemiology and burden of disease associated with HPV infection. Curr Obstet Gynecol Rep. 2016; 5:189-195.","DOI":"10.1007\/s13669-016-0174-y"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Doorbar J, Quint W, Banks L, Bravo IG, Stoler M, Broker TR, Stanley MA. The biology and life-cycle of human papillomaviruses. Vaccine. 2012; 30:55-70.","DOI":"10.1016\/j.vaccine.2012.06.083"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Angioli R, Lopez S, Aloisi A, Terranova C, Cicco CD, Scaletta G, Capriglione S, Miranda A, Luvero D, Ricciardi R, Montera R, Plotti F. Ten years of HPV vaccines: State of art and controversies. Crit Rev Oncol Hematol. 2016; 102:65-72.","DOI":"10.1016\/j.critrevonc.2016.03.020"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Hampson L, Martin-Hirsch P, Hampson IN. An overview of early investigational drugs for the treatment of human papilloma virus infection and associated dysplasia. Expert Opin Investig Drugs. 2015; 24:1529-1537.","DOI":"10.1517\/13543784.2015.1099628"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Zheng J, Deng YP, Lin C, Fu M, Xiao PG, Wu M. Arsenic trioxide induces apoptosis of HPV16 DNA-immortalized human cervical epithelial cells and selectively inhibits viral gene expression. Int J Cancer. 1999; 82:286-292.","DOI":"10.1002\/(SICI)1097-0215(19990719)82:2<286::AID-IJC21>3.0.CO;2-K"},{"key":"9","unstructured":"9. Tong XQ, Lv W, Luo WQ, Lu WX, Li N. Treatment of human cervical cancer cells with butein leads to apoptosis and DNA damage. Int J Clin Exp Med. 2016; 9:11084-11089."},{"key":"10","unstructured":"10. Li GL, Xia Q, Chen SH, Gui SQ, Xu CJ. Effects of Pinellia extract fraction on expressions of HPVE6 and P53 genes in cervical cancer cell lines. China J Tradit Chin Med Pharm. 2012; 27:113-116. (in Chinese)"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Munagala R, Aqil F, Jeyabalan J, Gupta RC. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer. Cancer Lett. 2015; 356:536-546.","DOI":"10.1016\/j.canlet.2014.09.037"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Deng WP, Chao MW, Lai WF, Sun C, Chung CY, Wu CC, Lin IH, Hwang JJ, Wu CH, Chiu WT, Chen CY, Redpath JL. Correction of malignant behavior of tumor cells by traditional Chinese herb medicine through a restoration of p53.Cancer Lett. 2006; 233:315-327.","DOI":"10.1016\/j.canlet.2005.03.031"},{"key":"13","unstructured":"13. Zhang XY, Bian ML, Fang Q, Chen QY, Chen ZH, Xu M. Study on the mechanism of the proliferative inhibition of Baofukang suppository on human papillomavirus in vitro. J China-Japan Friendship Hosp. 2007; 21:216-219+259. (in Chinese)"},{"key":"14","unstructured":"14. Shang YH, Bai LX, Wei LH. The molecular mechanism of Baofukang suppository as a potential inhibitor for cervical carcinoma cell. Chin J Clin Obstet Gynecol. 2003; 4:336-338+381. (in Chinese)"},{"key":"15","unstructured":"15. Xiao J, Wu J, Yu B, Xie HH. Therapeutic efficacy of Youdujing preparation in treating cervical high-risk human papilloma virus infection patients. Chin J Integr Tradit West Med 2012; 32:1212-1215. (in Chinese)"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Jiang EP, Sun XW, Kang HX, Sun LP, An WF, Yao YH, Hu XR. Dehydrocostus Lactone inhibits proliferation, antiapoptosis, and invasion of cervical cancer cells through PI3K\/Akt signaling pathway. Int J Gynecol Cancer. 2015; 25:1179-1186.","DOI":"10.1097\/IGC.0000000000000474"},{"key":"17","unstructured":"17. Xu YX, Yuan L. Improvement of cervical microenvironment and effect of Erhuang Powder on CIN I accompanied by human papillomavirus infection according to Th1\/Th2 immune balance. Liaoning J Tradit Chin Med. 2016; 43:962-965+1118. (in Chinese)"},{"key":"18","unstructured":"18. Dou BF, Zhang JG, Liu B. Analysis on effect of Modified Simiao Decoction in treatment of cervical HPV infection. Liaoning J Tradit Chin Med. 2013; 40:1141-1142. (in Chinese)"},{"key":"19","unstructured":"19. Cheng JM, Tong Y, Chen SC, Zhang L. Clinical effect of modified Simiao Decoction in treating cervical HPV infection. Pharm Clin Chin Mater Med. 2015; 31:149-150. (in Chinese)"},{"key":"20","unstructured":"20. He JM, Huo DZ, Chen YM. Influence of Yiqi Huashi Jiedu Decoction on TCM symptom score and HPV turn rate of cervicitis with HPV infection. Chin Arch Tradit Chin Med. 2015; 33:2390-2392. (in Chinese)"},{"key":"21","unstructured":"21. Bian ML, Chen QY, Zhu J, Ma L, Hao M, Liu J, Chen Y. The efficacy of baofukang suppository for treatment of cervicitis combined with persistant HPV infection. Chin J Pract Gynecol Obstet. 2010; 26:383-385. (in Chinese)"},{"key":"22","unstructured":"22. Shen JJ, Liu ZH, Li J, Zhou YQ, Wang C, Wu RF. The clinical observation for Baofukang and interferon in promoting the regression of low-grade cervical intraepithelial neoplasia. Chin J Clin Obstet Gynecol. 2013; 14:509-512. (in Chinese)"},{"key":"23","unstructured":"23. Wang YH, Wang F, Li YQ. Clinical study on treatment of cervical HPV infection by Radix Sophorae Flavescentis ointment. Med J Natl Defending Forces Southwest China. 2013; 23:189-191. (in Chinese)"},{"key":"24","unstructured":"24. Zhang Y, Wang XY, Ding ZY. Treatment of female patients with vaginal and cervical HPV infection. Chin J Infect Chemother. 2007; 7:293-294. (in Chinese)"},{"key":"25","unstructured":"25. Zhang MY. Clinical study on the interventive effect of realgar on the clearance of HPV and CIN. J Clin Exp Med. 2012; 11:580-581. (in Chinese)"},{"key":"26","unstructured":"26. Chen R, Zhao J, Liao QP. The clinical observation report of paiteling on treatment of CIN1\/2. Chin J Pract Gynecol Obstet. 2011; 27:703-705. (in Chinese)"},{"key":"27","unstructured":"27. Ma XL, Xue XO, Li S, Wang Y, Xie W. Clinical study of Zibai gel on treatment of cervical high-risk human papillomavirus infection. Chin J Inform TCM. 2012; 19:9-12.(in Chinese)"},{"key":"28","unstructured":"28. Xiao J, Huang JL, Cai LE. Study of Youdujing in treating HR-HPV infected cervical lesions. Guangdong Med J. 2011; 32:2036-2039. (in Chinese)"},{"key":"29","unstructured":"29. Hou MJ, Fan RQ, Sun J, Xuan GW, Chi FH. Effect of Chinese medicine Youdujing for human papilloma virus DNA. J Guangzhou Univ Tradit Chin Med. 1998; 15:57-60.(in Chinese)"},{"key":"30","unstructured":"30. Feng Y, Deng YH, Xuan GW, Zhou D, Sun J, Yuan XH, Zhao RZ. Preparation and in vitro pharmacodynamics effect of the Youdujing cream. Chin Hosp Pharm J. 2004; 24:7-8. (in Chinese)"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Ma C, Sivamani RK. Acupuncture as a treatment modality in dermatology: A systematic review. J Altern Complement Med. 2015; 21:520-529.","DOI":"10.1089\/acm.2014.0274"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Ursini T, Polilli E, Congedo G, Tontodonati M, Masi FD, Mazzotta E, Parruti G, Pippa L. Complete healing of a giant wart in a severely immune-compromised patient with HIV infection treated with acupuncture. Case Rep Dermatol. 2011; 3:175-180.","DOI":"10.1159\/000331427"},{"key":"33","unstructured":"33. Mai LX, Yang GZ, Yuan SH, Wang DN, Zhang T, Deng WC, Huang PJ. Effect of treatment by Chinese herbs for subclinical papillomavirus infection (SPI) and change of T cell subpopulation. Liaoning J Tradit Chin Med. 2016; 43:750-752. (in Chinese)"},{"key":"34","unstructured":"34. Ye LQ, Lou KL, Chen Y, Jiang Y. Clinical study of Chinese medicine intervention in treating cervical HR-HPV infection. Acta Chin Med Pharm. 2014; 42:79-82. (in Chinese)"},{"key":"35","unstructured":"35. Qin JL, Fu MX, Cheng JJ. Clinical effect of Chinese medicine and Baofukang in treating high-risk human papilloma virus. Modern J Integr Tradit Chin West Med. 2016; 25:1538-1540. (in Chinese)"},{"key":"36","unstructured":"36. Zhang PY, Wang XB, Xu X, Yang J, Yang HY. Study of intervention by traditional Chinese medicine for cervical precancerous lesion infected by high-risk HPV. Liaoning J Tradit Chin Med. 2010; 37:1191-1194. (in Chinese)"},{"key":"37","unstructured":"37. Chi Y, Li J. Ezhuyou-N-CWS carrier suppository for antagonizing HPV infection and preventing cervical cancer. J Beijing Univ Tradit Chin Med. 2009; 32:419-421. (in Chinese)"},{"key":"38","unstructured":"38. Wang Y, Su L, Kong WM, Wu YM, Duan W. Clinical study of CO2 laser combined with Baofukang suppository in the treatment of vaginal intraepithelial neoplasia with high risk HPV infection. Oncol Prog. 2016; 14:441-443+448. (in Chinese)"},{"key":"39","unstructured":"39. Zhao MJ, Wang SJ, Wei WH. Analysis of microwave therapy plus Baofukang in treating chronic cervicitis with high risk HPV infection. Matern Child Health Care China. 2013; 28:5730-5731. (in Chinese)"},{"key":"40","unstructured":"40. Yan LS, Yan JF. Clinical value of microwave therapy plus Baofukang in treating chronic cervicitis with HPV infection. Matern Child Health Care China. 2009; 24:4182-4183. (in Chinese)"},{"key":"41","unstructured":"41. Yu J, Yang HY, Zhang LJ, Zhang HP, Liu Y. Clinical study on the treatment of high risk HPV infection. Chin J Nosocomiol. 2016; 26:3069-3071. (in Chinese)"},{"key":"42","unstructured":"42. Xu JQ, Xu JG, Song XZ. Clinical observation of Baofukang combined with interferon in the treatment of cervical erosion complicated with HPV infection. Chin Arch Tradit Chin Med. 2014; 32:2028-2030. (in Chinese)"},{"key":"43","unstructured":"43. Li MX, Xue HY, Chen JP, Zhang XQ, Zhang YL. Effects of treatment efficacy and immune function of recombinant human interferon \u03b1-2b with Baofukang vaginal for patients combined with human papilomavirus infection. Chin J Nosocomiol. 2016; 26:3296-3298. (in Chinese)"},{"key":"44","unstructured":"44. Tang QJ, Guo SS, Wang ZZ. Clinical study of cervical HPV infection treated by Jiawei Jianpi Decoction combined with XinFuNing. Shanghai J Tradit Chin Med. 2016; 50:55-57. (in Chinese)"},{"key":"45","unstructured":"45. Xu X, Zhang B, Hao L, Gu J, Liu L, Wang X, Wu M, Zhang P, Cheng H. Combined use of Xunxi No. 1 and radiotherapy have clinical benefits in stage Ia-IIb cervical cancer patients with high-risk human papilloma virus infection. Minerva Biotecnol. 2014; 26:309-313. (in Chinese)"}],"container-title":["BioScience Trends"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/11\/3\/11_2017.01056\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,23]],"date-time":"2019-09-23T14:53:06Z","timestamp":1569250386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bst\/11\/3\/11_2017.01056\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.5582\/bst.2017.01056","relation":{},"ISSN":["1881-7815","1881-7823"],"issn-type":[{"value":"1881-7815","type":"print"},{"value":"1881-7823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}